Amedisys, Inc. (AMED) Thwomps Q2 Profit Views

Amedisys, Inc. (NASDAQ: AMED) reported Q2 EPS of $0.25, $0.21 better than the analyst estimate of $0.04. Revenue for the quarter came in at $305 million versus the consensus estimate of $298.9 million.

For earnings history and earnings-related data on Amedisys, Inc. (AMED) click here.

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Sharon AI surges premarket; New Oriental gains, Medline slips
• Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital